3-(3-tert-butyl-6,8-difluoro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)-N-cyclopropyl-5-fluoro-4-methylbenzamide

ID: ALA2087742

Cas Number: 1057394-06-5

PubChem CID: 25060093

Product Number: A286533, Order Now?

Max Phase: Preclinical

Molecular Formula: C21H21F3N4O

Molecular Weight: 402.42

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(F)cc(C(=O)NC2CC2)cc1-c1c(F)cn2c(C(C)(C)C)nnc2c1F

Standard InChI:  InChI=1S/C21H21F3N4O/c1-10-13(7-11(8-14(10)22)19(29)25-12-5-6-12)16-15(23)9-28-18(17(16)24)26-27-20(28)21(2,3)4/h7-9,12H,5-6H2,1-4H3,(H,25,29)

Standard InChI Key:  ZVBTZTQYHOXIBC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -3.2014  -16.8291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2026  -17.6565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4878  -18.0694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7713  -17.6560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7742  -16.8255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4896  -16.4164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0613  -16.4103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3453  -16.8201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0644  -15.5853    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3677  -16.4049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1916  -16.4056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7764  -15.6927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9174  -18.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4880  -18.8944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2078  -19.3028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7810  -20.1296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7772  -19.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4974  -20.5407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2070  -20.1247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8219  -20.6711    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4923  -21.4247    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6742  -21.3442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2409  -22.0410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6298  -22.7685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4164  -22.0140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8333  -22.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0623  -18.8901    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9209  -18.8879    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9160  -16.4168    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  3 14  1  0
 14 15  2  0
  5  7  1  0
  3  4  2  0
  7  8  1  0
 14 17  1  0
 15 19  1  0
 18 16  1  0
 16 17  2  0
 18 19  1  0
  7  9  2  0
  4  5  1  0
  8 10  1  0
 11 10  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 18  1  0
 12 11  1  0
 22 23  1  0
 10 12  1  0
 23 24  1  0
  2  3  1  0
 23 25  1  0
  5  6  2  0
 23 26  1  0
  6  1  1  0
 17 27  1  0
  2 13  1  0
 15 28  1  0
  1  2  2  0
  1 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA2087742

    AL 8697

Associated Targets(Human)

MAPK13 Tchem MAP kinase p38 delta (2605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RET Tclin Tyrosine-protein kinase receptor RET (6732 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (11336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.42Molecular Weight (Monoisotopic): 402.1667AlogP: 4.31#Rotatable Bonds: 3
Polar Surface Area: 59.29Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.57CX LogP: 3.85CX LogD: 3.85
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.71Np Likeness Score: -1.27

References

1. Aiguadé J, Balagué C, Carranco I, Caturla F, Domínguez M, Eastwood P, Esteve C, González J, Lumeras W, Orellana A, Preciado S, Roca R, Vidal L, Vidal B..  (2012)  Novel triazolopyridylbenzamides as potent and selective p38α inhibitors.,  22  (10): [PMID:22521646] [10.1016/j.bmcl.2012.03.099]
2. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek.  (2020)  Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection,  [10.21203/rs.3.rs-23951/v1]
3. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani.  (2020)  Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen,  [10.6019/CHEMBL4495564]
4. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen.  (2020)  Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort,  [10.6019/CHEMBL4495565]
5. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius.  (2021)  HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators,  [10.6019/CHEMBL4808148]